U.S. Medical Foods Market Size, Trends, Shares, Insights and Forecast – 2020-2027

1. U.S. MEDICAL FOODS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION U.S. Medical Foods Market - Overview U.S. Medical Foods Market, by Food Type (Prebiotics, Probiotics, and Food Supplements), by Disease Indication (Inflammatory Bowel Disease, Irritable Bowel Syndrome, and Others), and by Distribution Channel (Hospitals, Retail Channel, and Online Channel), was valued at US$ 10,991.5 million in 2019, and is expected to exhibit a CAGR of 17.1% over the forecast period (2019-2027), as highlighted in a new report published by . Key players in the market are focused on strengthening their market position by collaborating with other manufacturers for development and commercialization of efficient medical food products. For instance, in November 2018, Entrinsic Health Solutions (EHS), an innovative health sciences company entered into a partnership agreement with Nestlé Health Science, a global innovative leader pioneering nutritional health solutions for commercialization of Enterade is an electrolyte beverage containing amino acids and electrolyte designed for patients with gastrointestinal discomfort. Moreover, in 2017, Ferring Pharmaceuticals entered into an collaborative agreement with VSL Pharmaceuticals, Inc. for adopting marketing rights for its VSL3, a food supplement in the Europe market. VSL3 contains 450 billion live bacteria in eight different strains per sachet. Furthermore, in April 2017, Entera Health, Inc. and RedHill Biopharma, a specialty biopharmaceutical company, entered into a collaboration, in order to commercialize EnteraGam in the U.S. market. premium-quality, science-based Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/us- medical-foods-market-3215 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Browse 36 Market Data Tables and 30 Figures spread through 102 Pages and in-depth TOC on “U.S. Medical Foods Market”- Forecast to 2027, by Food Type (Prebiotics, Probiotics, and Food Supplements), by Disease Indication (Inflammatory Bowel Disease, Irritable Bowel Syndrome, and Others), and by Distribution Channel (Hospitals, Retail Channel, and Online Channel) Key players are focusing on strategic collaborations, in order to develop therapeutic agents and biomarkers for gastrointestinal diseases. For instance in January 2016, Enterome SA entered into a collaborative research agreement with Janssen Biotech, Inc. for discovery of novel targets and therapeutic agents for Crohn’s disease. Moreover, in January 2016, Takeda Pharmaceutical Company Ltd. and Enterome SA entered into a strategic drug discovery collaboration to research and develop potential microbiome-based new therapeutic agents for gastrointestinal disorders such as inflammatory bowel diseases. Key Takeaways of the U.S. Medical Foods Market: The U.S. medical foods market is expected to exhibit a CAGR of 17.1% over the forecast period, owing to increasing awareness about medical foods in the U.S. and rising risks of gastrointestinal disease such as Cohn’s diseases or ulcerative colitis in the U.S. For instance, according to the Crohn's & Colitis Foundation of America 2017 report, around 1.4 million people were affected from inflammatory bowel disease, of which 600,000 had Crohn’s disease or ulcerative colitis in the U.S. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3215 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Among food type, probiotic segment held a largest market share in 2018 owing to rising demand for medical foods and increasing presence of market players in U.S., is expected to propel growth of the probiotic market in the U.S. medical foods market over the forecast period. Among disease indication, irritable bowel syndrome (IBS) segment held a higher market share in 2018 owing to increasing patient pool suffering from IBS in the U.S. For instance, according to the International Foundation for Gastrointestinal Disorders (IFFGD) 2016, in the U.S., around 2.4 million and 3.5 million people visited hospitals and clinics, for the treatment of IBS. Companies operating in the U.S. medical foods market include Enterome SA, Yakult Honsha Co., Ltd., Abbott, ExeGi Pharma, LLC, VSL Pharmaceuticals, Inc., Entera Health, Inc., Meiji Holdings Co., Ltd., Danone, and Nestlé S.A. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3215 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved